Emtricitabine Interactions
There are 49 drugs known to interact with emtricitabine, along with 3 disease interactions. Of the total drug interactions, 14 are major, 34 are moderate, and 1 is minor.
- View all 49 medications that may interact with emtricitabine
- View emtricitabine disease interactions (3)
Most frequently checked interactions
View interaction reports for emtricitabine and the medicines listed below.
- Acetylsalicylic Acid (aspirin)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Aspirin Low Strength (aspirin)
- Atarax (hydroxyzine)
- Augmentin (amoxicillin / clavulanate)
- Benadryl (diphenhydramine)
- Calcarb with D (calcium / vitamin d)
- Celexa (citalopram)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Combivent (albuterol / ipratropium)
- Concerta (methylphenidate)
- Edurant (rilpivirine)
- Ethyl Alcohol (ethanol)
- Isentress (raltegravir)
- Lyrica (pregabalin)
- OxyContin (oxycodone)
- Paracetamol (acetaminophen)
- Quercetin (bioflavonoids)
- Restasis (cyclosporine ophthalmic)
- Seroquel (quetiapine)
- Tivicay (dolutegravir)
- Tramadol Hydrochloride ER (tramadol)
- Truvada (emtricitabine / tenofovir disoproxil)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin D3 (cholecalciferol)
- Vitamin K2 (menaquinone)
- Zyprexa (olanzapine)
- Zyrtec (cetirizine)
Emtricitabine disease interactions
There are 3 disease interactions with emtricitabine which include:
Report options
QR code containing a link to this page
More about emtricitabine
- emtricitabine consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
